Essential Medications for Palliative Care P-Drug List
A comprehensive palliative care P-drug list should include morphine, midazolam, haloperidol, and an antimuscarinic agent as the core essential medications, with additional medications for specific symptom management based on patient needs. 1
Core Essential Medications
Pain Management
- Morphine - First-line opioid for moderate to severe pain
- Starting dose: 5 mg PO every 4 hours for opioid-naive patients; 10 mg PO every 4 hours for patients previously on weak opioids 2
- For acute progressive dyspnea: 2.5-10 mg PO every 2 hours PRN or 1-3 mg IV every 2 hours PRN 3
- Patients on chronic opioids may need dose increases of approximately 25% 3
- Available in multiple formulations: oral solution, tablets, injectable forms 4
Anxiety, Agitation, and Sedation
- Midazolam - First-line benzodiazepine for anxiety, agitation, and palliative sedation
- Starting dose: 0.5-1 mg/hour continuous infusion or 1-5 mg PRN 3
- Usual effective dose: 1-20 mg/hour 3
- Advantages: Rapid onset, can be administered IV or SC, can be co-administered with morphine or haloperidol 3
- For refractory symptoms requiring sedation: Can be titrated to achieve desired level of sedation 5
Delirium and Nausea
- Haloperidol - First-line antipsychotic for delirium and nausea
Respiratory Secretions
- Antimuscarinic agent - For managing respiratory tract secretions
Additional Essential Medications by Symptom
Dyspnea Management
- Oxygen therapy - For symptomatic hypoxia 3
- Benzodiazepines - For dyspnea associated with anxiety
- Lorazepam: 0.5-1 mg PO every 4 hours PRN 3
Gastrointestinal Symptoms
Laxatives for constipation prevention and management
Anti-diarrheals
Antiemetics
Sleep Disturbances
- Trazodone: 25-100 mg PO at bedtime 3
- Mirtazapine: 7.5-30 mg PO at bedtime 3
- Zolpidem: 5 mg PO at bedtime 3
For Refractory Symptoms Requiring Deep Sedation
Phenobarbital
Propofol
Practical Considerations
- Medications for symptom palliation should be continued unless ineffective or causing distressing side effects 3
- Medications inconsistent with comfort goals can be discontinued 3
- Route of administration should be adjusted based on patient's condition (oral, IV, SC, rectal) 3
- Provision for breakthrough symptom management should always be included 3
- Pharmacokinetics may be altered in terminally ill patients due to physiological changes at end of life 7
- Consider dose adjustments for patients with renal or hepatic impairment 6
Common Pitfalls to Avoid
- Failing to distinguish between anxiety and delirium (benzodiazepines can worsen delirium) 3
- Using opioids alone for dyspnea when anxiety is a significant component 3
- Inadequate breakthrough dosing for pain and other symptoms 3
- Abrupt discontinuation of medications, especially opioids and benzodiazepines 3
- Prescribing liquid opioids in milliliters instead of milligrams when multiple concentrations are available 8
- Not making clear the indication and intended duration for steroids 8
- Using oxygen for symptomatic relief of breathlessness in the absence of hypoxia 8